FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. "To me, it's a help, it's an aid," says Cooper, 62, who lost ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss drugs. Set ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage Resolution Reshapes Weight Loss Medication LandscapeBluffdale, Dec.

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

If you knew a medicine wasn’t regulated or reviewed by the U.S. Food and Drug Administration, would you still be willing to take it? My guess is that most people wouldn’t willingly put an unknown ...

Many Americans have turned to compounding pharmacies to get popular weight-loss drugs due to lack of availability or expensive retail price tags. But this option will soon close for consumers. The ...

Julia Ingram is a data journalist for CBS News Confirmed. She uses data analysis and computation to cover misinformation, AI and social media. Readdy, who has struggled with her weight for most of her ...

Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty insurance coverage have driven some patients to seek out compounded ...